跳至主要内容
临床试验/NCT01748669
NCT01748669已完成2 期

Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Change in the clinical symptom of keratosis in palm

研究概览

简要总结

Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil capsule orally for 12 weeks to examine its effectiveness in reducing body arsenic load and clinical symptoms. Similar treatment with similar number of arsenic exposed controls and healthy volunteers will be included for comparison.

详细描述

Thousands of Bangladeshi are suffering from arsenic-induced keratosis affecting palms and soles. Palmer keratosis, particularly in young female, affects the socioeconomic condition. Till today there is no effective treatment.

Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil in soft capsule (10 mg/day) orally for 12 weeks. Similar treatment will be given to 20 arsenic exposed controls and 20 healthy volunteers for comparison. The aim of this study is to examine the effectiveness of oral administration of garlic oil to reduce body arsenic load and clinical symptoms of arsenical palmer keratosis.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • (Patients):
  • history of taking arsenic contaminated water (>50 ppb) for more than 6 months
  • patients having mild to moderate arsenical keratosis present on palm of the hand
  • patients those voluntarily agree to participate
  • Inclusion Criteria (Arsenic exposed controls):
  • family member of the patient
  • drinking arsenic contaminated water from the same source as patient
  • those voluntarily agree to participate
  • no sign/symptom of palmer keratosis
  • Inclusion Criteria (Healthy volunteers):
  • drinking arsenic safe water (<50 ppb)
  • those voluntarily agree to participate

排除标准

  • pregnancy
  • lactating mother
  • patient receiving treatment of arsenicosis
  • any other chronic disease like tuberculosis, diabetes mellitus, bronchial asthma

结局指标

主要结局

Change in the clinical symptom of keratosis in palm

时间窗: 0 week (baseline) to 12 weeks (end)

次要结局

  • Change in biochemical parameters (blood sugar, cholesterol and transaminase) after treatment(0 week (baseline), 12 weeks (end))
  • Adverse effects following treament(0 week (baseline), 12 weeks (end))
  • Change in the amount of arsenic in nail(0 week (baseline), 20 weeks (end))

研究者

发起方
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Mir Misbahuddin

Prof. and Chairman, Department of Pharmacology

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

研究点 (1)

Loading locations...

相似试验